Biomarkers in sepsis at time zero: Intensive care unit scores, plasma measurements and polymorphisms in Argentina

Journal of Infection in Developing Countries

Volumn 6, Issue 7, 2012, Pages 555-562

  Wingeyer, Silvia Perés ^a   Cunto, Eleonora ^a   Nogueras, Cristina ^a   Juan, Jorge San ^a   Norberto, Gómez ^a   de Larrañaga, Gabriela ^a  

^a HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

D dimer; PAI 1; Sepsis; SOFA; TNF

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; APACHE; ARGENTINA; ARTICLE; BLOOD CLOTTING TEST; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; TURBIDIMETRY;

EID: 84864472821     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2108     Document Type: Article

References (43)

1. Carlet J, Cohen J, Calandra T, Opal SM, Masur H (2008) Sepsis: time to reconsider the concept. Crit Care Med 36: 964-966.
2. Riedemann NC, Guo RF, Ward PA (2003) The enigma of sepsis. J Clin Invest 112: 460-467.
3. O'Brien JM, Jr., Ali NA, Aberegg SK, Abraham E (2007) Sepsis. Am J Med 120: 1012-1022.
4. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35: 1244-1250.
5. Moreno RP, Metnitz B, Adler L, Hoechtl A, Bauer P, Metnitz PG (2008) Sepsis mortality prediction based on predisposition, infection and response. Intensive Care Med 34: 496-504.
6. Esteban A, Frutos-Vivar F, Ferguson ND, Peñuelas O, Lorente JA, Gordo F, Honrubia T, Algora A, Bustos A, García G, Diaz-Regañón IR, de Luna RR. (2007) Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 35: 1284-1289.
7. Winning J, Claus RA, Huse K, Bauer M (2006) Molecular biology on the ICU. From understanding to treating sepsis. Minerva Anestesiol 72: 255-267.
8. Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101: 3765-3777.
9. O'Dwyer MJ, Mankan AK, Stordeur P, O'Connell B, Duggan E, White M, Kelleher DP, McManus R, Ryan T (2006) The occurrence of severe sepsis and septic shock are related to distinct patterns of cytokine gene expression. Shock 26: 544-550.
10. Emonts M, Hazelzet JA, de Groot R, Hermans PW (2003) Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 3: 565-577.
11. Vosylius S, Sipylaite J, Ivaskevicius J (2004) Sequential organ failure assessment score as the determinant of outcome for patients with severe sepsis. Croat Med J 45:715-720.
12. Arts DG, de Keizer NF, Vroom MB, de Jonge E (2005) Reliability and accuracy of Sequential Organ Failure Assessment (SOFA) scoring. Crit Care Med 33: 1988-1993.
13. Zygun DA, Laupland KB, Fick GH, Sandham JD, Doig CJ (2005) Limited ability of SOFA and MOD scores to discriminate outcome: a prospective evaluation in 1,436 patients. Can J Anaesth 52: 302-308.
14. Samransamruajkit R, Hiranrat T, Prapphal N, Sritippayawan S, Deerojanawong J, Poovorawan Y (2007) Levels of protein C activity and clinical factors in early phase of pediatric septic shock may be associated with the risk of death. Shock 28: 518-523.
15. H Heper Y, Akalin EH, Mistik R, Akgöz S, Töre O, Göral G, Oral B, Budak F, Helvaci S (2006) Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 25: 481-491.
16. Mesters RM, Florke N, Ostermann H, Kienast J (1996) Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis. Thromb Haemost 75: 902-907.
17. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC (2007) The use of gene-expression profiling to identify candidate genes in human sepsis. Am J Respir Crit Care Med 176: 676-684.
18. Texereau J, Pene F, Chiche JD, Rousseau C, Mira JP (2004) Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis. Crit Care Med 32 Suppl 5: 313-319.
19. Balding J, Healy CM, Livingstone WJ, White B, Mynett-Johnson L, Cafferkey M, Smith OP (2003) Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun 24: 533-540.
20. Holmes CL, Russell JA, Walley KR (2003) Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124: 1103-1115.
21. Tang BM, McLean AS, Dawes IW, Huang SJ, Cowley MJ, Lin RC (2008) Gene-expression profiling of gram-positive and gram-negative sepsis in critically ill patients. Crit Care Med 36: 1125-1128.
22. Raaphorst J, Johan Groeneveld AB, Bossink AW, Erik Hack C (2001) Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients. Thromb Haemost 86: 543-549.
23. Zeerleder S, Schroeder V, Hack CE, Kohler HP, Wuillemin WA (2006) TAFI and PAI-1 levels in human sepsis. Thromb Res 118: 205-212.
24. Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, Zakynthinos SG (2001) Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intensive Care Med 27: 1853-1859.
25. Kornelisse RF, Hazelzet JA, Savelkoul HF, Hop WC, Suur MH, Borsboom AN, Risseeuw-Appel IM, van der Voort E, de Groot R (1996) The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis 173: 1148-1156.
26. Renckens R, Roelofs JJ, Bonta PI, Florquin S, de Vries CJ, Levi M, Carmeliet P, Mvan't Veer C, van der Poll T (2007) Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood 109: 1593-1601.
27. Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR (2001) Low levels of protein C are associated with poor outcome in severe sepsis. Chest 120: 915-922.
28. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riché F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF (1999) Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282: 561-568.
29. G Geishofer G, Binder A, Müller M, Zöhrer B, Resch B, Müller W, Faber J, Finn A, Endler G, Mannhalter C, Zenz W (2005) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur J Pediatr 164: 486-490.
30. Haralambous E, Hibberd ML, Hermans PW, Ninis N, Nadel S, Levin M (2003) Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit Care Med 31: 2788-2793.
31. García-Segarra G, Espinosa G, Tassies D, Oriola J, Aibar J, Bové A, Castro P, Reverter JC, Nicolás JM (2007) Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent. Intensive Care Med 33: 1354-1362.
32. Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M (1999) 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 354: 556-560.
33. Jessen KM, Lindboe SB, Petersen AL, Eugen-Olsen J, Benfield T (2007) Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. BMC Infect Dis 7: 108.
34. Wolfler A, Silvani P, Musicco M, Antonelli M, Salvo I (2008) Incidence of and mortality due to sepsis, severe sepsis and septic shock in Italian Pediatric Intensive Care Units: a prospective national survey. Intensive Care Med 34: 1690-1697.
35. G Garnacho-Montero J, Aldabo-Pallas T, Garnacho-Montero C, Cayuela A, Jiménez R, Barroso S, Ortiz-Leyba C (2006) Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care 10(4): R111.
36. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589-1596.
37. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW (1988) Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318: 727-732.
38. Wingeyer SP, de Larranaga G, Cunto E, Fontana L, Nogueras C, San Juan J (2010) Role of 4G/5G promoter polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in outcome of sepsis. Thromb Res 125: 367-369.
39. Imahara SD, O'Keefe GE (2004) Genetic determinants of the inflammatory response. Curr Opin Crit Care 10: 318-24.
40. Menges T, König IR, Hossain H, Little S, Tchatalbachev S, Thierer F, Hackstein H, Franjkovic I, Colaris T, Martens F, Weismüller K, Langefeld T, Stricker J, Hempelmann G, Vos PE, Ziegler A, Jacobs B, Chakraborty T, Bein G (2008) Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factor. Crit Care Med 36: 1456-1462, e1-e6.
41. Orr N, Bekker V, Chanock S (2006) Genetic association studies: marking them well. J Infect Dis 194: 1475-1477.
42. Cooper DN, Nussbaum RL, Krawczak M (2002) Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet 110: 207-208.
43. El-Serag HB, White DL, Mitra N (2008) Genetic association studies: from "searching under the lamppost" to fishing in the pond. Gastroenterology 134: 662-664.